ScholarIQanswers from OpenAlex & ORCID
Pierre Amarenco
ResearcherPublications, citations & collaboration network
Pierre Amarenco is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Pierre Amarenco have?
ScholarIQindexed works
Pierre Amarenco has 648 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Pierre Amarenco have?
ScholarIQcitation count
Pierre Amarenco has 46,489 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Pierre Amarenco?
ScholarIQh-index
Pierre Amarenco has an h-index of 108 in OpenAlex.
What is the i10-index of Pierre Amarenco?
ScholarIQi10-index
Pierre Amarenco has an i10-index of 345 in OpenAlex.
What is the ORCID of Pierre Amarenco?
ScholarIQorcid
The ORCID for Pierre Amarenco is on the source record.
What is the OpenAlex record for Pierre Amarenco?
ScholarIQopenalex
The OpenAlex for Pierre Amarenco is on the source record.
What are the most-cited papers on Pierre Amarenco?
ScholarIQmost cited works
Lipoprotein(a) as a cardiovascular risk factor: current status
Børge G. Nordestgaard, M. John Chapman, Kausik K. Ray, Jan Borén, Felicita Andreotti, Gerald F. Watts, Henry N. Ginsberg, Pierre Amarenco, Alberico L. Catapano, Olivier Descamps, Edward A. Fisher, Petri T. Kovanen, Jan Albert Kuivenhoven, Philippe Lesnik, L. Masana, Željko Reiner, Marja‐Riitta Taskinen, Lâle Tokgözoğlu, Anne Tybjærg‐Hansen
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
M. John Chapman, Henry N. Ginsberg, Pierre Amarenco, Felicita Andreotti, Jan Borén, Alberico L. Catapano, Olivier Descamps, Edward A. Fisher, Petri T. Kovanen, Jan Albert Kuivenhoven, Philippe Lesnik, L. Masana, Børge G. Nordestgaard, Kausik K. Ray, Željko Reiner, Marja‐Riitta Taskinen, Lâle Tokgözoğlu, Anne Tybjærg‐Hansen, Gerald F. Watts, for the European Atherosclerosis Society Consensus Panel
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source
Robert G. Hart, Mukul Sharma, Hardi Mundl, Scott E. Kasner, Shrikant I. Bangdiwala, Scott D. Berkowitz, Balakumar Swaminathan, Pablo M. Lavados, Yongjun Wang, Yilong Wang, Antonio Dávalos, N. А. Shamalov, Robert Mikulík, Luís Cunha, Arne Lindgren, Antonio Araúz, Wilfried Lang, Anna Członkowska, Jens Eckstein, Rubens José Gagliardi, Pierre Amarenco, Sebastián F. Ameriso, Turgut Tatlisumak, Roland Veltkamp, Graeme J. Hankey, Danilo Toni, Dániel Bereczki, Shinichiro Uchiyama, George Ntaios, Byung‐Woo Yoon, Raf Brouns, Matthias Endres, Keith W. Muir, Natan M. Bornstein, Şerefnur Öztürk, Martin O’Donnell, Matthys M. De Vries Basson, Guillaume Paré, Calin Pater, Bodo Kirsch, Patrick Sheridan, Gary Peters, Jeffrey I. Weitz, W. Frank Peacock, Ashkan Shoamanesh, Oscar Benavente, Campbell Joyner, Ellison Themeles, Stuart J. Connolly
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
Daniel I. Swerdlow, David Preiss, Karoline Kuchenbaecker, Michael V. Holmes, Jorgen Engmann, Tina Shah, Reecha Sofat, Stefan Stender, P. Johnson, Robert A. Scott, Maarten Leusink, Niek Verweij, Stephen J. Sharp, Yiran Guo, Claudia Giambartolomei, Christina Lee Chung, Anne Peasey, Antoinette Amuzu, KaWah Li, Jutta Palmen, Philip Howard, Jackie A. Cooper, Fotios Drenos, Yun R Li, Gordon Lowe, John Gallacher, Marlene Stewart, Ioanna Tzoulaki, Sarah G. Buxbaum, Daphne L. van der A, Nita G. Forouhi, N. Charlotte Onland‐Moret, Yvonne T. van der Schouw, Renate B. Schnabel, Jaroslav A. Hubáček, Růžena Kubínová, Miglė Bacevičienė, Abdonas Tamošiūnas, Andrzej Pająk, Romanvan Topor-Madry, Urszula Stepaniak, Sofia Malyutina, Damiano Baldassarre, Bengt Sennblad, Elena Tremoli, Ulf dé Fairé, Fabrizio Veglia, Ian Ford, J. Wouter Jukema, Rudi G. J. Westendorp, Gert J. de Borst, Pim A. de Jong, Ale Algra, Wilko Spiering, Anke H. Maitland‐van der Zee, Olaf H. Klungel, Anthonius de Boer, Pieter A. Doevendans, Charles B. Eaton, Jennifer G. Robinson, David Duggan, John Kjekshus, John R. Downs, Antonio M. Gotto, Anthony Keech, Roberto Marchioli, Gianni Tognoni, Peter S. Sever, Neil R Poulter, David D. Waters, Terje R. Pedersen, Pierre Amarenco, Haruo Nakamura, John J.V. McMurray, James Lewsey, Daniel I. Chasman, Paul M. Ridker, Aldo P. Maggioni, Luigi Tavazzi, Kausik K. Ray, Sreenivasa Rao Kondapally Seshasai, JoAnn E. Manson, Jackie F. Price, Peter H. Whincup, Richard Morris, Debbie A. Lawlor, George Davey Smith, Yoav Ben‐Shlomo, Pamela J. Schreiner, Myriam Fornage, David S. Siscovick, Mary Cushman, Meena Kumari, Nick J Wareham, W. M. Monique Verschuren, Susan Redline, Sanjay R. Patel, John C. Whittaker, Anders Hamsten, Joseph A. Delaney
Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events
S. Matthijs Boekholdt, G. Kees Hovingh, Samia Mora, Benoît J. Arsenault, Pierre Amarenco, Terje R. Pedersen, John C. LaRosa, David D. Waters, David A. DeMicco, R. John Simes, Anthony Keech, David Colquhoun, G. A. Hitman, D. J. Betteridge, Michael Clearfield, John R. Downs, Helen M. Colhoun, Antonio M. Gotto, Paul M. Ridker, Scott M. Grundy, John J.P. Kastelein